Positron emission tomography (PET) studies with the selective 5-HT 1A receptor ligand, [ 11 C]WAY-100635, have indicated that the binding potential (BP) of brain 5-HT 1A receptors is lowered in unmedicated subjects with acute major depression. However, it is unclear if these changes persist after recovery from depression. To resolve this issue, we used [
Introduction
There is much evidence from both clinical and preclinical studies that brain serotonin (5-HT) neurotransmission is impaired in major depression and that pharmacological treatments that potentiate brain 5-HT function are effective antidepressant therapies. 1 Whether brain 5-HT neurotransmission returns to normal in recovered unmedicated depressed patients is less clear. For example, tests of 5-HT neuroendocrine function in recovered depressed subjects have given conflicting results. [2] [3] [4] [5] However, it does seem likely that people recovered from multiple episodes of depression are especially vulnerable to the moodlowering effects of dietary tryptophan depletion, 6 a technique that decreases brain 5-HT function by restricting precursor availability.
In a recent study in unmedicated depressed patients, we found widespread reductions in cortical postsynaptic 5-HT 1A receptor binding potential (BP) measured by positron emission tomography (PET) with [ 11 C]WAY-1006357. 7 We also found a similar reduction in binding of [ autoreceptors in the raphe nuclei in the midbrain. 7 These reductions persisted in depressed patients who responded clinically to treatment with selective serotonin reuptake inhibitors (SSRIs), 7 raising the possibility that the decrease in brain 5-HT 1A receptor binding seen in unmedicated depressed patients might be a trait abnormality, perhaps associated with vulnerability to depression. The present study aimed to test this hypothesis by measuring 5-HT 1A receptor binding in people with a history of recurrent unipolar depression who were euthymic and who had been free of psychotropic medication for at least 6 months.
Materials and methods

Subjects
A total of 14 male patients (mean age 48.0 years, standard deviation (SD) 14.9 years), who had experienced at least two episodes of major depression in the past (mean number of episodes 3.5, range 2-6) and had been euthymic (mean euthymic period 46 months, range 8-168 months) and free of psychotropic drugs for at least 6 months 8 (median drug-free period 29 months, range 8-60 months), were recruited for the study. The diagnosis of depression, previous episodes and period of euthymia were confirmed by a psychiatrist (ZB) using the Structured Clinical Interview for DSM-IV disorders Clinician Version (SCID). 9 Patients were excluded if they had any current depressive symptomatology, met criteria for any significant Axis I past psychiatric disorder other than depression or had a history of a serious medical or neurological illness or significant drug or alcohol abuse. They had a mean Hamilton Depression Rating Scale (HDRS) score of 2.3 (range 0-4) and a Beck Depression Inventory (BDI) score of 5.4 (range 1-9). All subjects gave written informed consent for the study, which was approved by the ethics committees at the Hammersmith Hospital, London and Oxford NHS Mental Healthcare NHS Trust. Permission to administer radionucleides was provided by the Administration of Radioactive Substances Advisory Committee, UK. A control group of 18 age-matched healthy male volunteers (mean age 43.2 years, SD 13.0 years), who had been scanned contemporaneously, were used as the control group. They were recruited from the community by advertisements and of these, 13 were part of a larger pool of subjects reported previously. 10 All control subjects were screened to exclude significant current or past medical or neurological illness, significant alcohol or drug abuse and past or current Axis I psychiatric illness.
PET scan acquisition PET scans were performed on an ECAT 953B PET camera with a 10.5 cm field of view in the z-axis (CTI/ Siemens, Knoxville, TN, USA) 11 in three-dimensional mode. A 10-min transmission scan was acquired in 2-D mode for correction of tissue attenuation of 511 keV g radiation using a retractable 68Ga/68Ge ring source. Dynamic emission data were acquired in 3-D mode using a standard acquisition protocol (21 time frames over 90 min) with dual window scatter correction. 12 All subjects were scanned using [ 11 C]WAY-100635 in the morning at approximately the same time and scans for both groups were performed concurrently over a 24-month period. [ 11 C]WAY-100635 was prepared at the Cyclotron Unit as described previously. 13 Structural magnetic resonance imaging (MRI) scans of the brain were obtained for all patients within a week of the PET scan to ensure that no subject had cerebral atrophy. 14 and parametric maps of BP and R 1 were generated. Test-retest variability for BP using this procedure is of the order of 1077% for postsynaptic regions and 17711% for the mid-brain raphe. 10 
Image analysis
Image analysis was performed as described previously. 10 In brief, cortical and limbic regions of interest (ROI) were defined on an averaged MRI image in MNI space (Montreal Neurological Institute) to create a generic ROI map. An [ (Table 1) . Using these values, we were able to calculate a representative value for global 5-HT 1A receptor binding (BP), adjusted for region size, in all postsynaptic regions in the brain. The raphe, which is undetectable on MRI, was defined manually on an integral image PET [
11 C]WAY-100635 image (20-90 min) for each individual. The cerebellum time-activity curves (each normalised to its peak) were plotted for all All values are mean7SD. No significant differences between groups on unpaired t-tests.
5-HT 1A receptors in recovered depressed subjects Z Bhagwagar et al subjects. In order to confirm the ROI analysis, parametric maps of BP and R 1 were examined using SPM99. As this was an anatomically defined hypothesis led analysis (global reduction of 5-HT 1A binding), P was thresholded at less than 0.001 uncorrected. For the SPM analysis, the BP and R 1 images were spatially normalised into Montreal Neurological Institute stereotactic space using a template made from [ 11 C]WAY-100635 scans of six healthy volunteers normalised to the T1 template in SPM99. Normalised BP images were smoothed with a Gaussian filter of 8 mm full-width at half-maximum, and R 1 images (which are statistically noisier), were smoothed with a filter of 16 mm full-width at half-maximum.
Statistical analysis
The results were analysed in two ways. In the first instance, we examined the two populations (pre-and postsynaptic) of 5-HT 1A receptors separately with univariate analysis of variance (ANOVA) with and without age as a covariate. We studied the mean BP of cortical and limbic regions, adjusted for region size, to represent postsynaptic binding and the value for the raphe to represent presynaptic binding. Next, BP values of all the brain regions were compared between controls and recovered depressed subjects using a repeated-measure ANOVA with Huynh-Feldt correction. For clarity, uncorrected degrees of freedom have been reported. Brain region was used as the withinsubjects factor and 'group' (controls vs recovered depressed patients) as the main between-subjects factor with age as a covariate. Significant group differences were further explored with post hoc t-tests (two-tailed). Pearson's product moment correlation coefficients (r) were obtained for average postsynaptic BP values against PET and clinical variables including total injected activity, specific activity, unlabelled 'cold' WAY-100635, WAY-100634 (precursor), age, HDRS and BDI score, age at onset of depression, number of previous episodes, total length of illness, months since last episode of depression, months since last taken antidepressant, past history of suicide attempts, family history of mood disorder and history of treatment with antidepressants. Owing to multiple correlations, the significance level for the Pearson correlations was set at Po0.01. All values are given as means7standard deviation (SD) unless specified otherwise. Statistical calculations were performed using SPSS 10.0 (SPSS Inc, Chicago, IL, USA).
Results
ROI analysis
There were no significant differences between patients and controls in the following PET variables; cerebellum time-activity curves, activity injected, specific activity, unlabelled WAY-100635, radiochemical purity of WAY-100635 or precursor WAY-100634 (see Table 1 ). Table 2 ). The only regions that did not show a significant lowering of BP were the left hippocampus and the left posterior cingulate cortex. There was no significant correlation of mean BP values with any PET or clinical variables (data not shown).
In the combined group of controls and recovered depressed subjects, age correlated negatively with mean postsynaptic BP (r¼À0.53; P¼0.007) and BP in the raphe (r ¼À0.62; P ¼0.001). This correlation was stronger in the patients than controls (postsynaptic, controls r ¼À0.326; P ¼0.24; patients, r ¼À0.89; P¼0.001. raphe, controls r¼À0.54, P¼0.039; patients r ¼À0.87, P ¼0.001). An ANOVA for the R 1 values showed no main effect of group (F 1,23 ¼2.56, P ¼0.12) or interaction between group and region (F 1,23 ¼0.62, P¼0.845).
SPM analysis
The results obtained with SPM analysis confirmed the findings of the ROI approach with significant reductions in BP in the recovered depressed patients being observed in widespread cortical regions except for the occipital cortex (Figure 1) . A further SPM analysis with age as a nuisance covariate was also performed with similar results (data not shown). In contrast, no changes in R 1 were seen between the two groups (data not shown).
Discussion
Our findings indicate that euthymic patients fully recovered from episodes of major depression and unmedicated for several months demonstrate substantial and widespread decreases in cortical BP for receptors or a decrease in receptor affinity. The present data do not allow us to distinguish between these possibilities. However, the abnormality in 5-HT 1A receptor BP seen in patients recovered from depression appears similar to that which we and others have reported in unmedicated acute depressed subjects. 7, 18, 19 There was, however, no change in the BP of [ 11 C]WAY-100635 in the raphe in recovered depressed subjects, while lowered raphe BP may be present in subjects experiencing an acute depressive episode. 7, 18 If this is the case, then it would suggest that 5-HT 1A autoreceptor binding might show normalisation with clinical recovery.
Like some other studies, 20, 21 we found that 5-HT 1A receptor binding decreased with age and, overall, there was a significant negative correlation between age and [ 11 C]WAY-100635 BP in both postsynaptic regions and the raphe. However, we found that this effect seemed to be more pronounced in the group of subjects recovered from depression. A possible explanation is that recurrent depressive disorder, or vulnerability to it, produces an exacerbation of the normal age-related decline in brain 5-HT 1A receptor availability.
The quantification of [ 5-HT 1A receptors in recovered depressed subjects Z Bhagwagar et al using both a kinetic analysis with arterial input function, 22, 23 and a simplified reference tissue model (SRTM) that obviates the need for arterial sampling and uses a cerebellar time-activity curve as an input function. 15 There is a general agreement on the utility of both the SRTM and the kinetic model in the quantification of [
11 C]WAY-100635 binding, although there is a disagreement on the preferred method. [23] [24] [25] The SRTM model has been criticised because it may result in a variable underestimation of BP and may be affected by changes in regional cerebral blood flow. In addition, the absence of an arterial input function, while more tolerable for subjects, precludes the measure of the total volume of distribution of tracer in the reference tissue (cerebellar V D ). 22, 24 While this paper does not aim to compare the merits of the two methods, we have made the following observations. Data obtained by our laboratory during methodological development showed that both models revealed similar reductions in 5-HT 1A BP in a group of acutely depressed patients relative to controls (data available on request from authors). In addition, our reported between-subject variability for [ 11 C]WAY-100635 binding of 17% using the SRTM, 10 compares favourably with that reported elsewhere for the arterial input model (20%, 22 23% 26 and 30% 23 ). Furthermore, the decrease in 5-HT 1A receptor BP in depression measured using the SRTM model has now been confirmed in a recent study using the arterial input function method. 19 It is also noteworthy that both methods give similar estimates of the ability of pindolol to displace the binding of [ 11 C]WAY-100635. 27, 28 We believe that the reduction in BP values in the patient group is unlikely to be an effect of altered blood flow as BP values in the SRTM are only minimally dependent on tracer delivery (R 1 ) 15 and regional R 1 values did not differ significantly between the two groups. However replication of our current findings in recovered depressed subjects, using an arterial input function, would be desirable.
Some studies have reported degrees of cerebral atrophy of populations of depressed patients, 29, 30, 31 which could be associated with lowered 5-HT 1A receptor availability. However, as noted in the Materials and methods section, all patients received structural MRIs of the brain that were checked to be free of cerebral atrophy. Some authors define ROIs on MRI scans coregistered to individual PET images. 17 We were not able to carry out this procedure because MRI scans were not available for all controls. We have, however, shown that spatial normalisation of an integral PET image to the [ 11 C]WAY-100635 PET template used in this study produces a definition of anatomical landmarks equivalent to that seen when individual MRIs and PET scans are coregistered. 17 However, future studies could usefully include this methodological refinement. Finally, it is important to note that we have not studied depressed women and controls and our findings cannot necessarily be extrapolated to this important group.
Our data support the notion that a decrease in postsynaptic 5-HT 1A receptor availability may be a trait marker of recurrent depression and therefore not linked directly to current mood state. Despite this, lowered postsynaptic 5-HT 1A receptor BP could play a part in the pathophysiology of acute depressive episodes. For example, in the presence of lowered postsynaptic 5-HT 1A receptor availability reductions in presynaptic 5-HT release could have a relatively greater impact on overall 5-HT neurotransmission. Such an effect could theoretically account for the greater vulnerability of recovered depressed patients to the mood lowering effects of tryptophan depletion. 6 The fact that we could not find any significant correlations in the recovered patients between the reduction in 5-HT 1A receptor BP and number of depressive episodes or duration of illness suggests that the lowered 5-HT 1A receptor BP is not simply a consequence of recurrent episodes of illness and their treatment. However, the relatively small sample size makes this conclusion tentative.
Further studies will be needed to determine the origin of the reduction in cortical 5-HT 1A receptor availability in those who have experienced recurrent depression. For example, if the abnormality is present prior to the onset of the depressive disorder, it could represent a marker of genetic inheritance or perhaps adverse childhood experience. In this respect, it is of interest that a recent study in mice indicated that failure to express postsynaptic 5-HT 1A receptors during a critical development period leads to an adult phenotype characterised by excessive anxiety, 32 a known risk factor for depression in humans. 33 A number of other factors relevant to the expression of cortical 5-HT 1A receptors need to be considered in the interpretation of our findings. For example, 5-HT 1A receptors are located on astrocytes 34, 35 as well as pyramidal neurones. 36 This raises the possibility that the reduction in 5-HT 1A receptor BP may be 5-HT 1A receptors in recovered depressed subjects Z Bhagwagar et al secondary to the glial loss reported in neuropathological studies of mood disorder. 37 Abnormalities of the hypothalamic-pituitary-adrenal (HPA) axis, especially hypercortisolaemia, have been implicated in the pathophysiology of depression 38 and prolonged exposure to glucocorticoids could lead to neuronal atrophy. 39 Increased cortisol secretion might also lead to decreased expression of 5-HT 1A receptors through genomic mechanisms, 40 and there is evidence that depressed patients continue to exhibit HPA axis overactivity even after clinical recovery. 41 These possibilities will need to be examined in further studies in order to improve our understanding of how decreased 5-HT 1A receptor availability may contribute to the pathophysiology of recurrent depression.
